ATRIUM THERAPEUTICS INCORPORATED (RNA)
Track the next or latest earnings date for ATRIUM THERAPEUTICS INCORPORATED, review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
stocktitan.net · 2026-07-31T20:17:41
Moderna’s Q2 2026 revenue was $145 million with a $782 million loss, as it booked $884 million of settlement-related royalties while maintaining $6,910 million in cash and investments.
Moderna (MRNA) Shares Drop After Q2 Earnings and Forecast Cutgurufocus.com · 2026-07-31T13:11:44
On July 31, 2026, Moderna Inc (MRNA) shares fell over 2% in pre-market trading following the release of its second-quarter earnings report, which included a dow
FinancialContent - Moderna (NASDAQ:MRNA) Beats Expectations in Q2 CY2026markets.financialcontent.com · 2026-07-31T11:14:03
Moderna (NASDAQ:MRNA) Beats Expectations in Q2 CY2026
Regeneron (REGN) Q2 2026 Earnings Call Transcript | The Motley Foolfool.com · 2026-07-31T00:42:30
Revenue surged 17% as Dupixent and EYLEA HD posted record sales.
Wave Life Sciences’ Earnings Call Highlights RNA Momentum - TipRanks.comwww.tipranks.com · 2026-07-31T00:20:48
Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks · Wave Life Sciences’ latest earnings call balanced robust clinical progress with sobering financial trends. Management highlighted powerful early data from its lead RNA ...
Upcoming earnings date
Time not specified
Fiscal quarter: 2026-06-30
EPS estimate: N/A
Revenue estimate: N/A
Market cap: $196.03M
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Aug 13, 2026 | 2026-06-30 | Time not specified | N/A | N/A |
| Feb 26, 2026 | 2025-12-31 | Time not specified | -$1.24 | N/A |